Nialamide (BioDeep_00000181654)

   

human metabolite blood metabolite


代谢物信息卡片


N-benzyl-3-(pyridin-4-ylformohydrazido)propanamide

化学式: C16H18N4O2 (298.1429688)
中文名称: 烟肼酰胺
谱图信息: 最多检出来源 Homo sapiens(blood) 85.05%

分子结构信息

SMILES: C1=CC=C(C=C1)CNC(=O)CCNNC(=O)C2=CC=NC=C2
InChI: InChI=1S/C16H18N4O2/c21-15(18-12-13-4-2-1-3-5-13)8-11-19-20-16(22)14-6-9-17-10-7-14/h1-7,9-10,19H,8,11-12H2,(H,18,21)(H,20,22)

描述信息

N - Nervous system > N06 - Psychoanaleptics > N06A - Antidepressants > N06AF - Monoamine oxidase inhibitors, non-selective
D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents
D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors
C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor

同义名列表

3 个代谢物同义名

N-benzyl-3-(pyridin-4-ylformohydrazido)propanamide; Nialamide; Niamid



数据库引用编号

8 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

1 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Tobie D Lee, Olivia W Lee, Kyle R Brimacombe, Lu Chen, Rajarshi Guha, Sabrina Lusvarghi, Bethilehem G Tebase, Carleen Klumpp-Thomas, Robert W Robey, Suresh V Ambudkar, Min Shen, Michael M Gottesman, Matthew D Hall. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular pharmacology. 2019 11; 96(5):629-640. doi: 10.1124/mol.119.115964. [PMID: 31515284]
  • Liusheng Huang, Florence Marzan, Anura L Jayewardene, Patricia S Lizak, Xiaohua Li, Francesca T Aweeka. Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for determination of isoniazid in human plasma. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2009 Jan; 877(3):285-90. doi: 10.1016/j.jchromb.2008.12.024. [PMID: 19112051]
  • H W Lambert, J M Lauder. Serotonin receptor agonists that increase cyclic AMP positively regulate IGF-I in mouse mandibular mesenchymal cells. Developmental neuroscience. 1999; 21(2):105-12. doi: 10.1159/000017372. [PMID: 10449982]
  • J Kärkkäinen, M Räisänen. Nialamide, an MAO inhibitor, increases urinary excretion of endogenously produced bufotenin in man. Biological psychiatry. 1992 Dec; 32(11):1042-8. doi: 10.1016/0006-3223(92)90066-9. [PMID: 1467384]
  • R E Poland, A Frazer. Corticosterone and prolactin response to TFMPP in rats during repeated antidepressant administration. The Journal of pharmacy and pharmacology. 1991 Jan; 43(1):54-6. doi: 10.1111/j.2042-7158.1991.tb05450.x. [PMID: 1676062]
  • K J Collard. On the mechanism by which extracellular sodium depletion causes 5-hydroxytryptamine release from rat brain synaptosomes. Biochimica et biophysica acta. 1989 Sep; 984(3):319-25. doi: 10.1016/0005-2736(89)90299-x. [PMID: 2789079]
  • D Hovevey-Sion, I J Kopin, R W Stull, D S Goldstein. Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma. Neuropharmacology. 1989 Aug; 28(8):791-7. doi: 10.1016/0028-3908(89)90169-x. [PMID: 2506486]
  • M Tatsuta, H Iishi, M Baba, H Taniguchi. Promotion by nialamide of gastric carcinogenesis induced by N-methyl-N'-nitro-N-nitrosoguanidine in Wistar rats. Japanese journal of cancer research : Gann. 1989 Jun; 80(6):521-5. doi: 10.1111/j.1349-7006.1989.tb01670.x. [PMID: 2503473]
  • J Buus Lassen. Nialamide-induced hypermotility in mice treated with inhibitors of monoamine uptake, 5-HT antagonists and lithium. Psychopharmacology. 1989; 98(2):257-61. doi: 10.1007/bf00444701. [PMID: 2526956]
  • I Lopez Aliaga, A Reche, M Barrionuevo, M S Campos. Influence of an inhibitor of monoaminooxidase (nialamide) on the serum levels, urinary excretion and plasma clearance of urea, uric acid and creatinine in adult and growing rats. Die Nahrung. 1989; 33(6):575-81. doi: NULL. [PMID: 2797116]
  • S M Evans, K J Collard. The mechanism by which monoamine oxidase inhibitors give rise to a non-calcium-dependent component in the depolarization-induced release of 5-HT from rat brain synaptosomes. British journal of pharmacology. 1988 Nov; 95(3):950-6. doi: 10.1111/j.1476-5381.1988.tb11725.x. [PMID: 3264736]
  • T Kato, M Katsuyama, N Karai, M Nakamura, J Katsube. Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice. Pharmacology, biochemistry, and behavior. 1987 Feb; 26(2):407-11. doi: 10.1016/0091-3057(87)90137-7. [PMID: 3106991]
  • E J Dial, J Huang, R Delansorne, L M Lichtenberger. Monoamine oxidase: an important intracellular regulator of gastrin release in the rat. Gastroenterology. 1986 Apr; 90(4):1018-23. doi: 10.1016/0016-5085(86)90881-4. [PMID: 3081396]
  • A Reche, M Barrionuevo, M S Campos, F Lisbona, F J Mataix. [Concentration of serum and hepatic transaminases (GOT and (GPT) in rats. Influence of nialamide]. Revista clinica espanola. 1984 Oct; 175(1):37-9. doi: NULL. [PMID: 6522713]
  • W E Heydorn, D J Brunswick, A Frazer. Effect of treatment of rats with antidepressants on melatonin concentrations in the pineal gland and serum. The Journal of pharmacology and experimental therapeutics. 1982 Sep; 222(3):534-43. doi: NULL. [PMID: 6286922]
  • K T Demarest, K E Moore. Type A monoamine oxidase catalyzes the intraneuronal deamination of dopamine within nigrostriatal, mesolimbic, tuberoinfundibular and tuberohypophyseal neurons in the rat. Journal of neural transmission. 1981; 52(3):175-87. doi: 10.1007/bf01249602. [PMID: 6796650]
  • F Kaloyanova, A Bainova, Z Zaprianov. Inhibition of monoamine oxidase activity after combined action of chlordimeform with the antidepressant nialamide. Archives of environmental contamination and toxicology. 1981; 10(1):1-8. doi: 10.1007/bf01057570. [PMID: 7235738]
  • J Buus Lassen, J Lund, E Bechgaard, I Søndergaard. Inhibition of 5-HT uptake into neurons and platelets in mice treated chronically with chlorimipramine and femoxetine. Psychopharmacology. 1979 Aug; 64(2):149-53. doi: 10.1007/bf00496055. [PMID: 115034]
  • E Johansson-Brittebo, H Tjälve. Studies on the tissue-disposition and fate of N-[14C]ethyl-N-nitrosourea in mice. Toxicology. 1979 Aug; 13(3):275-85. doi: 10.1016/s0300-483x(79)80031-1. [PMID: 230616]
  • B L Furman, G A Wilson. The effects of levodopa on plasma glucose in two strains of rat. European journal of pharmacology. 1979 May; 55(3):241-6. doi: 10.1016/0014-2999(79)90190-0. [PMID: 456422]
  • S A Darwish, B L Furman. Effects of levodopa and dopamine on plasma 11-hydroxycorticosteroid concentrations in mice. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 1979 Jan; 11(1):44-7. doi: 10.1055/s-0028-1092681. [PMID: 428907]
  • M Ikeno, K Oguchi, K Takahara, H Kinemuchi, K Kamijo. Specific characters of serum MAO in dogs. Biochemistry and experimental biology. 1978; 14(1):3-10. doi: NULL. [PMID: 743481]
  • D S Walter, G M Shilcock. Urinary 3-methoxy-4-hydroxyphenylglycol, an index of peripheral rather than central adrenergic activity in the rat. The Journal of pharmacy and pharmacology. 1977 Oct; 29(10):626-7. doi: 10.1111/j.2042-7158.1977.tb11418.x. [PMID: 21243]
  • P Montilla, R Muñóz, M C Bellido. [Effect of a monoamineoxidase inhibitor (Nialamide) on the daily fluctuation of plasma corticosterone]. Revista clinica espanola. 1977 Sep; 146(6):319-21. doi: NULL. [PMID: 201972]
  • A A Faiers, A Y Loh, D H Osmond. Resolution of rat renin substrates by isoelectric focusing. Canadian journal of biochemistry. 1977 Aug; 55(8):869-75. doi: 10.1139/o77-128. [PMID: 19143]
  • K Itaya, J Kiyonaga, M Ishikawa, K Mizuta. [Studies on gamma-oryzanol. III. Influence of gamma-oryzanol on circadian rhythms of serum gastrin, 11-OHCS and gastric secretion in rats (author's transl)]. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. 1977 May; 73(4):457-63. doi: NULL. [PMID: 20395]
  • S A Darwish, B L Furman. Effects of levodopa and dopamine of plasma glucose concentration in mice. European journal of pharmacology. 1977 Feb; 41(4):351-60. doi: 10.1016/0014-2999(77)90255-2. [PMID: 139316]
  • A X Pillar, C R Silva-Netto, L A Camargo, W A Saad, J Antunes-Rodrigues, M R Covian. Adrenergic stimulation of the lateral hypothalamic area on sodium and potassium excretion. Pharmacology, biochemistry, and behavior. 1977 Feb; 6(2):145-9. doi: 10.1016/0091-3057(77)90064-8. [PMID: 870902]
  • L A Camargo, W A Saad, C R Netto, C G Gentil, J Antunes-Rodrigues, M R Covian. Effects of catecholamines injected into the septal area of the rat brain on natriuresis, kaliuresis and diuresis. Canadian journal of physiology and pharmacology. 1976 Jun; 54(3):219-28. doi: 10.1139/y76-034. [PMID: 8200]
  • R Brus. Activity of some enzymes which synthesize and metabolize catecholamines in the brain and peripheral organs in developing rats. Archivum immunologiae et therapiae experimentalis. 1975; 23(4):449-57. doi: NULL. [PMID: 169762]
  • B L Furman. The hypoglycaemic effect of 5-hydroxytryptophan. British journal of pharmacology. 1974 Apr; 50(4):575-80. doi: 10.1111/j.1476-5381.1974.tb08591.x. [PMID: 4548658]
  • H Laborit, C Baron, J Laurent. [Effect of adrenolytic agents (alpha and beta blockaders), of a monoamine oxidase inhibitor and of an SH donor (Agr 307) on the serum glycuronidase increase induced by adrenaline infusion]. Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression. 1974; 15(2):111-5. doi: NULL. [PMID: 4447136]
  • L T Morozov. [Toxicity of a dimethoxyphenylethylamine incubate with the blood plasma of schizophrenia patients]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952). 1974; 74(3):396-8. doi: NULL. [PMID: 4466274]
  • E Anggård, B Sjöquist, B Fyrö, G Sedvall. Quantitative determination of homovanillic acid in serum by mass fragmentography. European journal of pharmacology. 1973 Oct; 24(1):37-42. doi: 10.1016/0014-2999(73)90111-8. [PMID: 4756167]
  • L Gupta, R P Garg, R C Sharma, R B Arora. Monoamine oxidase inhibiting activity of Daucus carota. Indian journal of experimental biology. 1973 Jul; 11(4):342-3. doi: ". [PMID: 4783391]
  • S Parvez, D Gripois, H Parvez. Urinary excretion of adrenalin, noradrenalin and vanylmandelic acid in rats during pregnancy and post-partum. Effects of niamide and reserpine administration. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme. 1973 May; 5(3):207-12. doi: 10.1055/s-0028-1093954. [PMID: 4714548]
  • P K Das. Further evidence on the heterogeneity of 'silent' serum cholinesterase variants. Human heredity. 1973; 23(1):88-96. doi: 10.1159/000152559. [PMID: 4742045]
  • N S Buslenko, B A Kuznetsova. [Levels of serotonin in the blood and 5-hydroxyindoleacetic acid in the urine of patients with ischemic heart disease]. Kardiologiia. 1972 Sep; 12(9):39-43. doi: NULL. [PMID: 4644951]
  • M Kassab, A Zohdy, S A Tawab. The changes in the serotonin (5-hydroxytryptamine) content of kidney tissue and urine under the influence of diuretic drugs after treatment with monoamineoxidase inhibitors. The Journal of the Egyptian Medical Association. 1972; 55(7):502-11. doi: NULL. [PMID: 4657615]
  • L S Petelin, K A Tret'iakova, V A Pigarev, L K Romenskaia. [Pathochemical bases for the treatment of parkinsonism]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952). 1971 Dec; 71(12):1765-70. doi: NULL. [PMID: 5143959]
  • K D Charalampous. Comparison of metabolism of mescaline and 3,4-dimethoxyphenylethylamine in humans. Behavioral neuropsychiatry. 1971 Feb; 2(11):26-9 passim. doi: NULL. [PMID: 5566331]
  • B Cuparencu, B Czitron. A study of the effects of monoamine oxidase inhibitors on the experimental gastric and duodenal ulcers. Acta biologica et medica Germanica. 1971; 27(4):753-62. doi: NULL. [PMID: 5211463]
  • M J Mercier, A S Curry. [Enzymatic method for the detection of monoamine oxidase inhibitors]. European journal of toxicology. 1971 Jan; 4(1):36-8. doi: NULL. [PMID: 5092664]
  • L V Devoino, L S Yeliseyeva. Influence of some drugs on the immune response. 3. Effect of serotonin, 5-hydroxytryptophan, reserpine, monoamine oxidase inhibitors, and DOPA on the involvement of lymph node cells in the immune response. European journal of pharmacology. 1971; 14(1):71-6. doi: 10.1016/0014-2999(71)90124-5. [PMID: 5313885]
  • J J Gagliardino, R E Hernandez, R R Rodriguez, H C Lauri. Stimulatory effect of nialamide on serum levels on insulin. The American journal of physiology. 1970 Aug; 219(2):314-7. doi: 10.1152/ajplegacy.1970.219.2.314. [PMID: 5448059]
  • A Jus, H Rosengarten, H Wardaszko-Lyskowska, A Szemis, K Stencka, I Wlosińska, J Krzyzowski, K Kowalska. [Correlation between disturbances of tryptophan metabolism induced by methionine and nialamide administration and changes of the mental state in chronic schizophrenic patients]. Psychiatria polska. 1970 Jul; 4(4):365-71. doi: NULL. [PMID: 5472573]
  • H Rosengarten, K Stencka, K Kowalska, H Wardaszko-Lyskowska, A Szemis, I Wlosińska, J Krzyzowski, A Jus. [Disturbances of tryptophan metabolism during methionine and nialamide administration in chronic schizophrenic patients]. Psychiatria polska. 1970 May; 4(3):261-8. doi: NULL. [PMID: 5459695]
  • B Prytz, C E Grossi, L M Rousselot. In vitro formation of ammonia in blood of g and man. Clinical chemistry. 1970 Apr; 16(4):277-9. doi: 10.1093/clinchem/16.4.277. [PMID: 4986070]
  • V M Ognivenko, V I Iakubovskaia. [Effect of niamid on cholesterol metabolism based on atherogenic diet]. Farmakologiia i toksikologiia. 1970 Jan; 33(1):31-4. doi: NULL. [PMID: 5425611]
  • M L Michailov, B Zografski, P Dimitrov, M Zlateva. [Administration of monoamine oxidase inhibitors in experimental atherosclerosis]. Zeitschrift fur Alternsforschung. 1970; 23(2):145-52. doi: ". [PMID: 5509070]
  • M Kalin, B Kylin, T Malmfors. The effect of nitrate explosives on adrenergic nerves. Archives of environmental health. 1969 Jul; 19(1):32-5. doi: 10.1080/00039896.1969.10666801. [PMID: 4977647]
  • V M Ognivenko. [The effect of different periods of niamide administration on some indices of lipid metabolism]. Farmakologiia i toksikologiia. 1969 Jul; 32(4):453-6. doi: ". [PMID: 5357464]
  • A De Schaepdryver, P Preziosi, U Scapagnini. Brain monoamines and adrenocortical activation. British journal of pharmacology. 1969 Mar; 35(3):460-7. doi: 10.1111/j.1476-5381.1969.tb08287.x. [PMID: 4309262]
  • I Munkacsi. Distribution of the intrarenal monoaminergic nerves in the kidneys of the desert rat (Dipodomys merriami) and the white rat (Rattus norvegicus). Acta anatomica. 1969; 73(1):56-68. doi: NULL. [PMID: 5344888]
  • I Machtey. [Pyrexia following nialamide]. Dapim refuiim. Folia medica. 1968 Dec; 27(7):279-80. doi: NULL. [PMID: 5732936]
  • V Z Gorkin, L A Romanova. On the selective inhibition by some monoamine oxidase inhibitors of deamination of biogenic monoamines in vivo. Biochemical pharmacology. 1968 Jun; 17(6):855-60. doi: 10.1016/0006-2952(68)90343-2. [PMID: 5661349]
  • Y Ito. The tissue catecholamine concentration of the rabbit in experimental cardiac failure. Japanese circulation journal. 1968 May; 32(5):761-72. doi: 10.1253/jcj.32.761. [PMID: 5755069]
  • P Henry, Y Nedelec, R Merland. [Studies on the blood concentration and urinary excretion of Nialamide during treatment]. Annales medico-psychologiques. 1968 Feb; 1(2):276-85. doi: NULL. [PMID: 5651951]
  • H Koźlicka-Gajdzińska, H Sybirska. [Quantitative determination of nialamide with cation exchange paper in suicidal poisoning]. Archiv fur Toxikologie. 1968; 23(3):226-32. doi: NULL. [PMID: 5704792]
  • D S Robinson, W Lovenberg, H Keiser, A Sjoerdsma. Effects of drugs on human blood platelet and plasma amine oxidase activity in vitro and in vivo. Biochemical pharmacology. 1968 Jan; 17(1):109-19. doi: 10.1016/0006-2952(68)90163-9. [PMID: 4384242]
  • T Pawlikowski, J Kolaszyński, M Karasek. [Effect of reserpine and niamide on the morphology and lipid content of the adrenal cortex of the white rat]. Endokrynologia Polska. 1968 Jan; 19(1):101-6. doi: ". [PMID: 5668888]
  • A Weissman, B K Koe. m-Fluorotyrosine convulsions and mortality: relationship to catecholamine and citrate metabolism. The Journal of pharmacology and experimental therapeutics. 1967 Jan; 155(1):135-44. doi: NULL. [PMID: 5297377]
  • A Madej, W Pakszys. [Psychic and motor functions and serotonin (5-HT) metabolism in encephalopathic children prior to and following administration of niamid and raupasil]. Neurologia, neurochirurgia i psychiatria polska. 1966 Oct; 16(10):1123-8. doi: NULL. [PMID: 5993461]
  • J Pokora. Effect of Serpasil, Niamid and Deseril on the excretion of 5-hydroxyindoloacetic acid in diurnal urine and on oxidase activity of ceruloplasmin in human serum. Polish medical journal. 1966; 5(3):716-22. doi: . [PMID: 5920288]
  • J Pokora. The effect of serpasil, niamid and deseril on the excretion of 5-hydroxyindolacetic acid in diurnal urine and on oxidase activity of ceruloplasmin in human serum. Polish medical science and history bulletin. 1965 Oct; 8(4):154-7. doi: . [PMID: 5857859]
  • J POKORA. [EFFECT OF SERPASIL, NIAMIDE AND DESERIL ON THE EXCRETION OF 5-HYDROXYINDOLACETIC ACID IN DAILY URINE AND ON THE OXIDASE ACTIVITY OF CERULOPLASMIN IN HUMAN BLOOD SERUM]. Polski tygodnik lekarski (Warsaw, Poland : 1960). 1965 Jan; 20(?):1-4. doi: . [PMID: 14325111]
  • W Nowak. [Studies on the effect of niamide on the serum lipids level and on the bleeding and clotting times in the patients with thoracic croup]. Przeglad lekarski. 1965; 21(11):680-3. doi: NULL. [PMID: 5861473]
  • A Pekkarinen, U Rinne, E Iisalo. Prolonged decrease in vanilmandelic (3-Methoxy-4-hydroxymandelic) acid excretion by man during and after nialamide treatment. Acta pharmacologica et toxicologica. 1965; 22(4):331-9. doi: 10.1111/j.1600-0773.1965.tb01828.x. [PMID: 5898267]
  • W Bettschart, J P Broché, R Tissot. [Correlation of the clinical and pharmaco-dynamic effects of Niamid in the treatment of severely mentally retarded children]. Annales paediatrici. International review of pediatrics. 1965; 205(3):216-33. doi: NULL. [PMID: 4221631]
  • J QUINTERORANGEL, R NARANJOJIMENEZ. [NIALAMIDE IN EXPERIMENTAL HEPATIC AND RENAL INSUFFICIENCY]. Revista de investigacion. 1964 Dec; 4(?):114-7. doi: NULL. [PMID: 14322692]
  • R ANTOGNETTI, A E TAMMARO. [OBSERVATIONS ON URINARY CATECHOLAMINES IN AGED SUBJECTS TREATED WITH NIALAMIDE]. Giornale di gerontologia. 1964 Sep; 12(?):1013-6. doi: NULL. [PMID: 14258408]
  • G FRANDOLI, A GIBELLI, E RAMOVECCHI. [STUDY ON FIBRINOLYSIS, THE LIPID FRACTIONS AND LIVER FUNCTION IN ATHEROSCLEROTIC PATIENTS TREATED WITH NIALAMIDE FOR 2 MONTHS]. Folia clinica internacional. 1964 Sep; 14(?):402-15. doi: ". [PMID: 14206383]
  • N A TAUTZ, E SCHMID, D BENTE. [RESULTS AND PROBLEMS OF CLINICAL EXPERIMENTAL STUDIES ON THE METABOLISM OF BIOGENIC AMINES]. Arzneimittel-Forschung. 1964 Jun; 14(?):SUPPL:505-11. doi: NULL. [PMID: 14253950]
  • H OSADA. THE EFFECTS OF RESERPINE, ALPHA-METHYL DOPA, NIALAMIDE AND DEXAMETHASONE ON THE UPTAKE AND METABOLISM OF H3-CATECHOLAMINE--MAINLY IN REGARD TO THE CARDIOVASCULAR SYSTEM OF HUMAN AND RABBITS. Japanese heart journal. 1964 May; 5(?):224-42. doi: 10.1536/ihj.5.224. [PMID: 14170438]
  • L MAINIERI, P L CIPOLLI. [RENAL FUNCTION DURING THE COURSE OF TREATMENT WITH MONOAMINO-OXIDASE INHIBITORS]. Rivista di patologia e clinica. 1964 Jan; 19(?):40-5. doi: NULL. [PMID: 14165772]
  • Z HERMAN. [EFFECT OF NIAMIDE ON THE BLOOD LEVEL 5-HYDROXYTRYPTAMINE AND ON THE URINARY EXCRETION OF 5-HYDROXYINDOLACETIC ACID IN PATIENTS WITH MALIGNANT CARCINOID SYNDROME]. Polskie Archiwum Medycyny Wewnetrznej. 1964; 34(?):1317-22. doi: NULL. [PMID: 14275304]
  • J M DAVID. [RECENT KNOWLEDGE ABOUT THE PROBLEM OF PHENYLPYRUVIC OLIGOPHRENIA. FREQUENCY, GENETICS, BIOCHEMISTRY, DIAGNOSIS, AND THERAPEUTICS]. La Semana medica. 1963 Oct; 123(?):1191-206. doi: NULL. [PMID: 14098630]
  • K STOCK, E O WESTERMANN. CONCENTRATION OF NOREPINEPHRINE, SEROTONIN, AND HISTAMINE, AND OF AMINE-METABOLIZING ENZYMES IN MAMMALIAN ADIPOSE TISSUE. Journal of lipid research. 1963 Jul; 4(?):297-304. doi: 10.1016/s0022-2275(20)40306-2. [PMID: 14168167]
  • R JORAY, H NAEF, G RITZEL, E SIEGRIST. [NIAMID IN A DOUBLE BLIND EXPERIMENT IN DISTURBED SCHOOL CHILDREN]. Annales paediatrici. International review of pediatrics. 1963; 201(?):SUPPL:60-70. doi: NULL. [PMID: 14168089]
  • E SANNER. TUBULAR EXCRETION OF DOPAMINE (3-HYDROXYTYRAMINE) BY THE CHICKEN KIDNEY. Acta pharmacologica et toxicologica. 1963; 20(?):375-84. doi: 10.1111/j.1600-0773.1964.tb01760.x. [PMID: 14162822]
  • A RETT, T KOHLMANN, E FRUEHMANN. [CLINICAL AND PHARMACO-PSYCHOLOGICAL TESTS IN THE USE OF SO-CALLED PSYCHO-ENERGIZERS (WITH SPECIAL REFERENCE TO NIAMID)]. Annales paediatrici. International review of pediatrics. 1963; 201(?):SUPPL:71-99. doi: NULL. [PMID: 14168090]
  • K B BJORNESJO, B JARNULF. Determination of iproniazid and nialamide in blood serum and urine. Scandinavian journal of clinical and laboratory investigation. 1962; 14(?):408-15. doi: 10.3109/00365516209079729. [PMID: 13869625]
  • E SCHUELLER. [Corticosteroid excretion after nialamide medication]. Wiener klinische Wochenschrift. 1960 Nov; 72(?):856-7. doi: NULL. [PMID: 13748752]